TKL Research History

TKL Research is a clinical research organization (CRO) with decades of experience in clinical trial management. Beginning as a supplier of medical diagnostics, TKL has evolved into a company that exclusively provides clinical research services and has maintained steady, measured growth that is fundamental to our commitment to budgets, timelines and quality in all of the services we provide.

TKL opened its first clinic for single-center trials more than fifty years ago. Over the last 25 years, we have opened five additional research clinics in the United States and Europe.

During the mid 1990s, TKL began providing services as a clinical research organization (CRO). With continuing growth, in 2006, we moved our CRO operations to our current US headquarters in Rochelle Park, NJ and in 2010, expanded our European capabilities with clinical operations headquartered in Münster, Germany.

With focused attention on phase 1-4 clinical trials for pharmaceutical, biotechnology, medical device and consumer healthcare clients, TKL provides experience and expertise in most therapeutic areas, including:

  • Dermatology CRO
  • Endocrinology/Metabolic Diseases
  • Gastroenterology
  • Gynecology/Urology
  • Pain Management
  • OTC Products
  • Respiratory/Allergy
  • Vaccines and Infectious Diseases
  • Oral Health
  • Devices and Diagnostics
  • Ophthalmology

TKL intends to continue its international expansion to provide clinical research services to meet our sponsors’ needs.